Endometriosis Market Swot Analysis, Porters Five Forces Analysis, Forecast Till 2027

Increasing awareness about women's health, increasing occurrence rate of the condition, the rising focus on clinical trials are some of the factors boosting the endometriosis market. 

Market Size – USD 1.93 Billion in 2018, Market Growth - CAGR of 2.8%, Market Trends –The increasing focus on clinical trial.

The Global Endometriosis Market is forecast to reach USD 2.42 Billion by 2026, according to a new report by Reports and Data. Endometriosis is the resultant of the growth of endometrial tissue on bowel, ovaries, and tissues lining the pelvis. The hormonal changes associated with the menstrual cycle impacts the misplaced endometrial tissue that results in the area to become inflamed that causes pain. It implies that the tissue will thicken, grow, and break down. With time, the tissue that broken down has nowhere to go and becomes trapped in pelvis.

The market is projected to witness considerable growth during the forecast period. One of the mentionable factors in this regards being, the increasing occurrence rate of the condition. It has turned out to be a common gynecological condition, affecting approximately 10% of women. Treatment for the disease is dependent on the severity of the disease, symptoms, and if the care user wishes to have children. The condition is treatable with surgery, medication, or both. Medication is usually tried first when pain is the primary problem.

Ask for Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/2553

Medications that are prescribed to treat the condition include pain relievers like nonsteroidal anti-inflammatory drugs (NSAIDs), and hormonal medications, including gonadotropin-releasing hormone agonists and birth control pills, progestin. Hormonal medications help minimize the growth of the endometrial tissue and may prevent the formation of new adhesions. Though it is mentionable that, these drugs are usually not effective in getting rid of endometriosis tissue that is already there. In regards to surgical options, Conservative surgery like Laparoscopy, hysterectomy are some of the available options.

In context to region, Europe occupies a prominent market position. The market position held by the region is resultant of the continuous growth of the healthcare sector and rising investment in the industry.   

Further key findings from the report suggest

·         The endometriosis market held a market share of USD 1.93 Billion in the year 2018 and forecasted to grow at a rate of 2.8% during the forecast period.

·         In regards to Drug Type, the NSAID’s segment generated the highest revenue of USD 0.58 Billion in 2018, with a growth rate of 2.9% during the forecast period. The effectiveness of the medicine in relieving pain caused by the condition, which are nonsteroidal anti-inflammatory drugs that work by discontinuing the release of prostaglandins that is one of the main chemicals resulting in the pain, contributes to the revenue generated by the NSAID’s segment.

·         In context to Surgery Type, the Laparoscopy segment yielded the highest revenue of USD 0.87 Billion in 2018, with the fastest growth rate of 3.2% during the forecast period. The effectiveness of this surgery in accurately diagnosing endometriosis and even eliminate it in mild-moderate condition with just a small incision resulted in its increased demand and revenue generated by the    

·         In regards to the End-users, the Drugstores segment can be seen to occupy the largest market share of 30.2% in 2018, with the second-highest growth rate of 3.1% during the forecast period. The fact that in most cases of endometriosis, pain in the primary issue, in which medication is the first choice, has resulted in high dependency on drugstores for availing the prescribed medication, which contributes to the market share occupied by this segment.

·         In context to region, Asia Pacific is projected to witness the fastest growth rate of 5.5% during the forecast period, which occupied the second-largest market share of 24.3% in 2018. The growth rate experienced by the Asia Pacific region is resultant of continuous growth in healthcare technology and the rising awareness about women’s health.

·         Key participants include Johnson & Johnson Services Inc., Bayer AG, Neurocrine Biosciences Inc., Meditrina Pharmaceuticals Inc., AbbVie Inc., Astellas Pharma Inc., AstraZeneca Plc, Evotec AG, Debiopharm Group and Teva Pharmaceutical Industries Ltd.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2553

For the purpose of this report, Reports and Data have segmented the global endometriosis market based on Surgery Type, Drug Type, End-Users, and region:

Surgery Type Outlook (Revenue, USD Billion; 2016-2026)

·         Laparoscopy

·         Laparotomy

·         Pelvic nerves surgery

Drug Type Outlook (Revenue, USD Billion; 2016-2026)

·         NSAID’s

·         Gonadotropins Releasing Hormone Agonists

·         Progestin

·         Oral Contraceptive Pills

End-Users Type Outlook (Revenue, USD Billion; 2016-2026)

·         Hospital

·         Pharmacies

·         Drugstores

·         E-commerce

Regional Outlook (Revenue, USD Billion; 2016-2026)

·         North America

o    U.S

·         Europe

o    U.K

o    France

·         Asia Pacific

o    China

o    India

o    Japan

·         MEA

·         Latin America

o    Brazil

To know more about the report @ https://www.reportsanddata.com/report-detail/endometriosis-market

 Key Features of the Endometriosis Market Report:

·         The report encompasses details about the key companies, product portfolio along with specifications, production valuation, and market shares

·         Extensive study of key segments and sub-segments of the Endometriosis market

·         Evaluation of key current and emerging market trends and growth prospects

·         Brief overview of industry with regards to research and development, technological advancements, and product development

·         In-depth assessment of upstream raw materials, downstream buyers, demands, and current market scenario

·         Analysis of key drivers, restraints, opportunities, growth prospects, limitations, and threats

·         Strategic recommendation to key players and new entrants to overcome entry-level barriers in the Endometriosis market over the forecast period

Table of Content:

Chapter 1. Market Synopsis
    1.1. Market Definition
    1.2. Research Scope & Premise
    1.3. Methodology
    1.4. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2018-2026
Chapter 3. Indicative Metrics
Chapter 4. Endometriosis Market Segmentation & Impact Analysis
    4.1. Endometriosis Market Material Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
                  4.2.2.1. Increasing awareness about women health
                  4.2.2.2. Increasing occurrence rate of the condition
                  4.2.2.3. The rising focus on clinical trials
         4.2.3. Market restraints analysis
                 4.2.3.1. Lack of awareness about the preventive measures and causes for the disease
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. ETOP Analysis
    4.6. Porter’s Five Forces Analysis
    4.7. Competitive Metric Space Analysis
    4.8. Price trend Analysis
Chapter 5. Endometriosis Market By Surgery Type Insights & Trends

Continued….

Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.